 | Up a level |
Jump to: 2016
Number of items: 1.
2016
Freeman, C. L., Dixon, M., Houghton, R., Kreuzer, K-A, Fingerle-Rowson, G., Herling, M., Humphrey, K., Boettcher, S., de Costa, C. S., Iglesias, V., Stilgenbauer, S., Gribben, J., Hallek, M. and Goede, V. (2016). Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab. Leukemia, 30 (8). S. 1763 - 1768. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551